levodopa has been researched along with Apoplexy in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.27) | 18.2507 |
| 2000's | 18 (40.91) | 29.6817 |
| 2010's | 23 (52.27) | 24.3611 |
| 2020's | 2 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Kuric, E; Marklund, N; Ruscher, K; Talhada, D; Wieloch, T | 1 |
| Abe, H; Jitsuki, S; Takahashi, T | 1 |
| Banu, NR; Bhattacharjee, M; Das, UK; Kamal, MZ; Rahman, MA; Saha, G; Sarker, UK; Shill, SK; Talukder, RK; Uddin, MJ | 1 |
| Häggman Henrikson, J; Pombo Antunes, AR; Ruscher, K; Wieloch, T | 1 |
| Catoira, NP; Di Girolamo, G; González, CD; Viale, L | 1 |
| Cramer, SC; Finklestein, SP; Lin, DJ | 1 |
| Bhakta, BB; Cozens, A; Farrin, AJ; Ford, GA; Hartley, S; Holloway, I; Meads, D; Pearn, J; Ruddock, S; Sackley, CM; Saloniki, EC; Santorelli, G; Walker, MF | 1 |
| Acler, M; Manganotti, P | 1 |
| Kuric, E; Ruscher, K; Wieloch, T | 2 |
| Chondrogiorgi, M; Konitsiotis, S; Reichmann, H; Tatsioni, A | 1 |
| Kuric, E; Ruscher, K | 1 |
| Chang, MC; Jang, SH; Kwon, YM | 1 |
| Baumgärtner, A; Breitenstein, C; Dobel, C; Flöel, A; Knecht, S; Korsukewitz, C; Zwitserlood, P | 1 |
| Cramer, SC | 1 |
| Cristovam, Rdo A; Fussiger, H; Marrone, AC; Marrone, LC; Martins, WA; Taietti, MZ; Vedana, VM | 1 |
| Bonato, P; Daneault, JF; Fregni, F; Gallegos, JG; Pajaro-Blazquez, M; Pons, J; Tran, DA; Zafonte, R | 1 |
| Chan, WY; Choo, M; Ge, Y; Ju, H; Kok, S; Ng, YS; Oey, NE; Samuel, GS; Van Dongen, AM | 1 |
| Breitenstein, C; Flöel, A; Heuschmann, P; Knecht, S; Rösser, N; Wersching, H | 1 |
| Członkowska, A; Leśniak, M; Litwin, M; Litwin, T; Seniów, J | 1 |
| Acler, M; Fiaschi, A; Manganotti, P | 1 |
| Delbari, A; Lokk, J; Salman Roghani, R | 1 |
| Nowak, DA; Reiner, B; Seidel, B | 1 |
| Abo, M; Fukuda, A; Ito, H; Kakuda, W; Kobayashi, K; Momosaki, R; Tominaga, A; Yokoi, A | 1 |
| Delbari, A; Lokk, J; Salman-Roghani, R | 1 |
| Barman, KK; Majumder, S; Masihuzzaman, AM; Uddin, MJ; Ullah, MA | 1 |
| Lo, AC; Mernoff, ST | 1 |
| Hatano, T; Hattori, N; Kubo, S; Niijima-Ishii, Y; Sugita, Y | 1 |
| Cheng, TI; Cheng, TJ; Chiang, SC | 1 |
| Ianishevskiĭ, SN; Kovalenko, PA; Lobzin, SV; Odinak, MM; Vozniuk, IA | 1 |
| Breitenstein, C; Cohen, LG; Floel, A; Hummel, F; Knecht, S | 1 |
| Lökk, J; Sonde, L | 1 |
| Liepert, J; Restemeyer, C; Weiller, C | 1 |
| Gardoni, F | 1 |
| Orta Daniel, SJ; Ulises, RO | 1 |
| Kikuchi, K; Nishino, K; Ohyu, H | 1 |
| Villringer, A | 1 |
| Gniekowski, F | 1 |
| Allen, DG; Brown, LK; Brown, SL; Guilmette, TJ; Mukand, JA; Tober, KL; Vandyck, WR | 1 |
| Fries, W; Koenig, E; Müller, F; Scheidtmann, K | 1 |
| Ahangar, B; Burke, DT; Chae, H; Frates, EP | 1 |
| Baracchini, C; Burlina, AB; Burlina, AP; Carollo, C | 1 |
| Arai, H; Sasaki, H; Satou, T; Wada, H | 1 |
| Goichot, B; Vinzio, S | 1 |
9 review(s) available for levodopa and Apoplexy
| Article | Year |
|---|---|
Pharmacological Enhancement of Stroke Rehabilitation.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Humans; Levodopa; Neuronal Plasticity; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Stroke; Stroke Rehabilitation; Synapses | 2019 |
Pharmacotherapy and motor recovery after stroke.
Topics: Amphetamines; Animals; Dopamine Agents; Humans; Levodopa; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Stroke; Stroke Rehabilitation | 2018 |
New Directions in Treatments Targeting Stroke Recovery.
Topics: Brain-Computer Interfaces; Carbidopa; Cell- and Tissue-Based Therapy; Chorionic Gonadotropin; Dopamine Agonists; Drug Combinations; Epoetin Alfa; Humans; Levodopa; Occupational Therapy; Physical Therapy Modalities; Recovery of Function; Robotics; Selective Serotonin Reuptake Inhibitors; Speech Therapy; Stroke; Stroke Rehabilitation; Telerehabilitation; Transcranial Direct Current Stimulation; Transcranial Magnetic Stimulation; Vagus Nerve Stimulation; Virtual Reality | 2018 |
Role, indications and controversies of levodopa administration in chronic stroke patients.
Topics: Dopamine Agents; Humans; Levodopa; Recovery of Function; Stroke; Stroke Rehabilitation | 2013 |
Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials.
Topics: Databases, Bibliographic; Dopamine Agonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Levodopa; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2014 |
Drugs to Enhance Motor Recovery After Stroke.
Topics: Cholinesterase Inhibitors; Donepezil; Dopamine Agents; Humans; Indans; Levodopa; Motor Activity; Motor Skills; Piperidines; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Stroke; Stroke Rehabilitation | 2015 |
Combining Dopaminergic Facilitation with Robot-Assisted Upper Limb Therapy in Stroke Survivors: A Focused Review.
Topics: Combined Modality Therapy; Dopamine Agents; Exercise Therapy; Hemiplegia; Humans; Levodopa; Neuronal Plasticity; Robotics; Stroke; Stroke Rehabilitation; Survivors; Upper Extremity | 2016 |
Novel stroke rehabilitation interventions.
Topics: Central Nervous System Stimulants; Exercise Therapy; Humans; Levodopa; Neuronal Plasticity; Phosphodiesterase Inhibitors; Physical Therapy Modalities; Recovery of Function; Restraint, Physical; Robotics; Selective Serotonin Reuptake Inhibitors; Stroke; Stroke Rehabilitation | 2011 |
MAGUK proteins: new targets for pharmacological intervention in the glutamatergic synapse.
Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Chronic Disease; Disks Large Homolog 4 Protein; Dyskinesia, Drug-Induced; Glutamic Acid; Guanylate Kinases; Humans; Huntington Disease; Intracellular Signaling Peptides and Proteins; Levodopa; Membrane Proteins; Pain; Protein Subunits; Receptors, N-Methyl-D-Aspartate; Stroke; Synapses | 2008 |
14 trial(s) available for levodopa and Apoplexy
| Article | Year |
|---|---|
Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Carbidopa; Dopamine Agents; Double-Blind Method; Drug Combinations; Female; Humans; Intracranial Hemorrhages; Levodopa; Male; Middle Aged; Mobility Limitation; Occupational Therapy; Physical Therapy Modalities; Prospective Studies; Stroke; Stroke Rehabilitation; Treatment Outcome | 2019 |
L-dopa does not add to the success of high-intensity language training in aphasia.
Topics: Adult; Aged; Aphasia; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Language Tests; Language Therapy; Levodopa; Male; Middle Aged; Nootropic Agents; Prospective Studies; Stroke; Stroke Rehabilitation; Treatment Outcome | 2015 |
Combining levodopa and virtual reality-based therapy for rehabilitation of the upper limb after acute stroke: pilot study Part II.
Topics: Acute Disease; Aged; Biomechanical Phenomena; Computer Simulation; Dopamine; Dopamine Agents; Extremities; Female; Humans; Levodopa; Male; Middle Aged; Movement; Paresis; Pilot Projects; Single-Blind Method; Stroke; Stroke Rehabilitation; Treatment Outcome; Virtual Reality Exposure Therapy | 2017 |
Levodopa improves procedural motor learning in chronic stroke patients.
Topics: Aged; Carbidopa; Chronic Disease; Cross-Over Studies; Dopamine Agents; Double-Blind Method; Female; Germany; Humans; Levodopa; Male; Middle Aged; Motor Skills; Placebos; Reaction Time; Statistics, Nonparametric; Stroke; Stroke Rehabilitation; Treatment Outcome | 2008 |
New approach to the rehabilitation of post-stroke focal cognitive syndrome: effect of levodopa combined with speech and language therapy on functional recovery from aphasia.
Topics: Adult; Aged; Aphasia; Cognition Disorders; Combined Modality Therapy; Dopamine Agents; Double-Blind Method; Female; Humans; Language Tests; Language Therapy; Levodopa; Male; Middle Aged; Prospective Studies; Recovery of Function; Speech Therapy; Stroke; Stroke Rehabilitation; Syndrome; Treatment Outcome | 2009 |
Long-term levodopa administration in chronic stroke patients. A clinical and neurophysiologic single-blind placebo-controlled cross-over pilot study.
Topics: Aged; Aged, 80 and over; Biophysical Phenomena; Cross-Over Studies; Dopamine Agents; Electric Stimulation; Electromyography; Evoked Potentials, Motor; Female; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Motor Activity; Pilot Projects; Single-Blind Method; Statistics, Nonparametric; Stroke; Time Factors; Transcranial Magnetic Stimulation | 2009 |
Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke--a randomized, double-blind, placebo-controlled trial.
Topics: Activities of Daily Living; Aged; Central Nervous System Stimulants; Combined Modality Therapy; Dopamine Agents; Double-Blind Method; Female; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Physical Therapy Modalities; Recovery of Function; Stroke | 2011 |
Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Central Nervous System Stimulants; Cognition Disorders; Double-Blind Method; Female; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Mood Disorders; Neuropsychological Tests; Physical Therapy Modalities; Psychiatric Status Rating Scales; Retrospective Studies; Stroke; Time Factors; Treatment Outcome | 2011 |
[Madopar in the complex therapy of ischemic insult].
Topics: Aged; Aged, 80 and over; Benserazide; Blood Pressure; Brain Ischemia; Cognition; Dopamine Agents; Drug Administration Schedule; Drug Combinations; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Stroke; Treatment Outcome | 2005 |
Dopaminergic effects on encoding of a motor memory in chronic stroke.
Topics: Aged; Aged, 80 and over; Brain; Chronic Disease; Cross-Over Studies; Dopamine; Dopamine Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levodopa; Male; Memory; Middle Aged; Motor Skills; Movement; Movement Disorders; Muscle, Skeletal; Neuronal Plasticity; Paresis; Recovery of Function; Stroke; Thumb; Treatment Outcome | 2005 |
Effects of amphetamine and/or L-dopa and physiotherapy after stroke - a blinded randomized study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Combined Modality Therapy; Dextroamphetamine; Dopamine Agents; Double-Blind Method; Female; Humans; Levodopa; Male; Physical Therapy Modalities; Stroke; Stroke Rehabilitation; Treatment Outcome | 2007 |
No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study.
Topics: Aged; Chronic Disease; Cross-Over Studies; Dopamine Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Pilot Projects; Recovery of Function; Stroke; Transcranial Magnetic Stimulation; Treatment Failure | 2007 |
Dopaminergic therapy with carbidopa L-dopa for left neglect after stroke: a case series.
Topics: Activities of Daily Living; Aged; Carbidopa; Dopamine Agents; Female; Geriatric Assessment; Humans; Levodopa; Perceptual Disorders; Severity of Illness Index; Stroke; Treatment Outcome | 2001 |
Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study.
Topics: Aged; Dopamine Agents; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Physical Therapy Modalities; Stroke; Stroke Rehabilitation | 2001 |
21 other study(ies) available for levodopa and Apoplexy
| Article | Year |
|---|---|
Plasticity-Enhancing Effects of Levodopa Treatment after Stroke.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Down-Regulation; GAP-43 Protein; Infarction, Middle Cerebral Artery; Levodopa; Male; Mice; Neuronal Plasticity; Nogo Proteins; Nogo Receptors; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Rats, Wistar; Stroke; Thrombosis | 2021 |
Motor Outcome of Stroke Patients with Low Dose Levodopa Therapy.
Topics: Aged; Bangladesh; Disabled Persons; Dopamine Agents; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Disorders; Prospective Studies; Quality of Life; Stroke | 2019 |
Enhanced functional recovery by levodopa is associated with decreased levels of synaptogyrin following stroke in aged mice.
Topics: Animals; Brain; Dopamine Agents; Levodopa; Mice, Transgenic; Neuronal Plasticity; Neurons; Receptors, Dopamine D1; Receptors, Dopamine D2; Recovery of Function; Stroke; Synaptogyrins | 2020 |
Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke.
Topics: Analysis of Variance; Animals; Astrocytes; Brain; Brain Infarction; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dopamine Agents; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Levodopa; Male; Nestin; Rats; Rats, Wistar; Receptors, Dopamine; Stroke | 2013 |
Reversal of stroke induced lymphocytopenia by levodopa/benserazide treatment.
Topics: Animals; Benserazide; Drug Combinations; Levodopa; Lymphopenia; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Remission Induction; Single-Blind Method; Stroke; Treatment Outcome | 2014 |
Serotonin syndrome in stroke patients.
Topics: Carbidopa; Dopamine Agonists; Drug Combinations; Humans; Indoles; Levodopa; Male; Middle Aged; Serotonin Syndrome; Stroke | 2015 |
Holmes' tremor as a delayed complication of thalamic stroke.
Topics: Aged; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Male; Stroke; Thalamus; Tremor | 2016 |
Tremor following ischemic stroke of the posterior thalamus.
Topics: Carbidopa; Dopamine Agents; Female; Humans; Hypercholesterolemia; Hypertension; Levodopa; Magnetic Resonance Imaging; Middle Aged; Stroke; Thalamus; Tremor | 2010 |
Combination treatment of low-frequency rTMS and occupational therapy with levodopa administration: an intensive neurorehabilitative approach for upper limb hemiparesis after stroke.
Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Female; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Muscle Spasticity; Neuropsychological Tests; Occupational Therapy; Paresis; Pilot Projects; Psychomotor Performance; Recovery of Function; Stroke; Stroke Rehabilitation; Transcranial Magnetic Stimulation; Treatment Outcome; Upper Extremity | 2011 |
Effect of low dose levodopa on motor outcome of different types of stroke.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Humans; Levodopa; Longitudinal Studies; Middle Aged; Motor Activity; Stroke | 2011 |
Levodopa treatment improves functional recovery after experimental stroke.
Topics: Animals; Antiparkinson Agents; Astrocytes; Benserazide; Blotting, Western; Cell Hypoxia; Cells, Cultured; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Combinations; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Glucose; Immunohistochemistry; Infarction, Middle Cerebral Artery; Levodopa; Male; Rats; Rats, Wistar; Receptors, Dopamine; Recovery of Function; Stroke | 2012 |
Levodopa-responsive Parkinsonism following bilateral putaminal hemorrhages.
Topics: Antiparkinson Agents; Female; Functional Laterality; Humans; Levodopa; Middle Aged; Parkinsonian Disorders; Putaminal Hemorrhage; Stroke | 2013 |
Association of aspirin with eosinophilia in peripheral blood.
Topics: Aged; Antiparkinson Agents; Aspirin; Eosinophilia; Humans; Levodopa; Male; Parkinson Disease; Platelet Aggregation Inhibitors; Stroke | 2004 |
Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus.
Topics: Antiparkinson Agents; Female; Humans; Levodopa; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Stroke; Substantia Nigra | 2008 |
L-DOPS-Accelerated recovery of locomotor function in rats subjected to sensorimotor cortex ablation injury: pharmacobehavioral studies.
Topics: Animals; Benserazide; Brain; Cerebral Cortex; Dopamine Agents; Droxidopa; Drug Therapy, Combination; Levodopa; Male; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Stroke | 1999 |
[Study patients recover better from stroke. L-dopa: doping for the apolpexy brain? (interview by Waldtraud Paukstadt].
Topics: Clinical Trials as Topic; Combined Modality Therapy; Levodopa; Physical Therapy Modalities; Stroke; Stroke Rehabilitation | 2001 |
[Elderly patients. Patients not fitting into a category are labeled as Alzheimer disease patients].
Topics: Aged; Alzheimer Disease; Diagnosis, Differential; Humans; Learning; Levodopa; Mental Recall; Stroke | 2001 |
Post-stroke violent adventitial movement responsive to levo-dopa/carbi-dopa therapy.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Basal Ganglia; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Movement Disorders; Stroke; Treatment Outcome; Tremor | 2001 |
Propionic acidaemia with basal ganglia stroke: treatment of acute extrapyramidal symptoms with L-DOPA.
Topics: Adolescent; Basal Ganglia Diseases; Humans; Levodopa; Magnetic Resonance Imaging; Male; Propionates; Stroke | 2001 |
[The prevention of pneumonia in the elderly by dopamine agonists].
Topics: Aged; Amantadine; Angiotensin-Converting Enzyme Inhibitors; Dopamine Agonists; Humans; Levodopa; Pneumonia, Aspiration; Stroke | 2001 |
Levodopa and recovery after stroke.
Topics: Aged; Dopamine Agents; Humans; Levodopa; Stroke; Treatment Outcome | 2002 |